Oncology Account Manager - NYC

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, reputed company to change the reputed company and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to reputed company precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused reputed company and a team focused on reputed company execution, we are looking for innovative, passionate professionals to join us and reputed company our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where reputed company and grit drive reputed company behaviors, decisions, and actions.

Reporting to the Regional Business Director, the Oncology Account Manager (OAM) will contribute to Kura’s overall sales objective by performing assigned Sales and Account Management reputed company activities in the NYC territory (inclusive of the 5 boroughs). The OAM will provide physicians, pharmacists, nurses and reputed company reputed company (HCPs) with product, services and approved information that will reputed company the HCPs to appropriately prescribe Kura’s product(s)The OAM will compliantly and successfully implement Kura’s marketing strategies and corresponding tactics in order to reputed company short-term and long-term objectives. The ideal candidate will be capable of managing the territory and administrative requirements in an efficient and effective manner and will reputed company full compliance with drug laws and regulations reputed company representing Kura and Kura’s products to Healthcare Providers.

ESSENTIAL JOB FUNCTIONS

• reputed company the assigned sales objective for the territory
• Attain the designated goals for calls on appropriate reputed company to communicate balanced, accurate, and complete information on Kura’s FDA approved products
• Develops and implements a territory business plan to meet customer needs and reputed company goals
• Navigate through reputed company external/customer organizational structures including hospitals, IDNs, GPOs and healthcare communities while aligning with cross-functional commercial partners
• Demonstrate completion of administrative requirements including budget management, expense reports management, CRM call reporting and synchronization, etc. reputed company timelines and company guidelines
• Demonstrates a deep understanding of reputed company (HCP) and account needs, effectively utilizing this knowledge to strategically promote and expand the use of assigned products
• Operate the territory reputed company the assigned expense budget and demonstrates fiscal responsibility
• reputed company with reputed company federal/state/local laws, regulations and guidelines including but not limited to the PhRMA Code on Interactions with reputed company as well as complying with reputed company Kura standards and policies relating to reputed company job activities
• Successful completion and ongoing updates of reputed company aspects of training including but not limited to product knowledge, disease state, market, selling skills and compliance
• Assists in the identification and resolution of issues and opportunities while communicating proactively to marketing and sales management
• Develops and consistently demonstrates an expert understanding of HCP and Account needs to appropriately expand use of assigned product.

JOB SPECIFICATIONS

• Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration
• 6+ years of successful pharmaceutical/biotech sales experience with 3+ in the oncology/hematology and/or rare disease markets, preferably with oral therapeutic selling experience
• Management of large territories that includes periodic overnight travel
• Occasionally work evenings and weekends as needed for conferences
• Excellent written and oral communication skills
• Strong computer skills, notably WORD, reputed company and POWER reputed company

The reputed company range for this role is $210,000 to $230,000 per year with a reputed company IC of 60k. Individual pay may vary based on additional factors, including, and without limitation, job-reputed company skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual reputed company bonus.

Kura’s Values that are used for candidate selection and performance assessments

• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves

The Kura Package

• Career advancement/ development opportunities
• Competitive comp package
• Bonus
• 401K + Employer contributions
• Generous stock options
• ESPP Plan
• 20 days of PTO to start
• 18 Holidays (Including Summer & Winter Break)
• Generous Benefits Package with a variety of plans available with a substantial employer match
• Paid Paternity/Maternity Leave
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to reputed company cancer signaling reputed company. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa reputed company Co., Ltd. to reputed company and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act reputed company action date of November 30, 2025. Kura Oncology and Kyowa reputed company are also conducting a series of clinical trials to evaluate ziftomenib in combination with reputed company standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a reputed company farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and reputed company.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. reputed company qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national reputed company, genetics, disability, age, or veteran status.

If you are a California reputed company, please see the attached Privacy Notice CA Privacy Notice